Search
Search for Bupa recognised healthcare professionals and services.
+ any details

Dr Mark Verrill

Medical oncology

 

  • Fee assured
Overview

Specialises in

  • Bone
  • Breast
  • Soft tissue

About me

Mark Verrill studied Medicine at the University of Cambridge and University College London, qualifying in 1989. He was awarded Membership of the Royal College of Physicians in 1993 and Fellowship in 2003. He undertook oncology Training at the Royal Marsden Hospital and institute of Cancer Research, London. He was appointed Cancer Research UK Senior Lecturer in Medical Oncology at Newcastle University and Honorary Consultant Medical Oncologist in the Newcastle Hospitals Trust in 1999. He moved in to his current NHS post in 2007.

He is internationally respected for his clinical trials work in breast cancer and regarded as a "key opinion leader". He has lectured on breast cancer all over the world.

Areas of interest

Breast Cancer; Gastro-intestinal stroll tumours; Soft Tissue Sarcoma

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • AA844

    Clinical supervision and planning for delivery of chemotherapy cycle in the member's home 1-28 days - (5-50)

  • AA843

    Clinical supervision and planning for delivery of chemotherapy cycle in the member's home 1-21 days - (5-50)

  • X0003

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 21 days - (1-5)

Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and these third parties declare it to be correct and compliant with their relevant regulatory bodies' standards and codes of conduct. We're unable to guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use here.